TherapeuticsMD (TXMD) Cash from Investing Activities (2011 - 2022)
TherapeuticsMD's (TXMD) quarterly Cash from Investing Activities came in at -$74000.0 in Q4 2022, up 95.11% YoY from -$37926.9 in Q4 2021, and down 1157.14% on a QoQ basis from $7000.0 in Q3 2022.
TherapeuticsMD (TXMD) Cash from Investing Activities (2011 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has 12 years of Cash from Investing Activities data on file, last reported at -$74000.0 in Q4 2022.
- Quarterly Cash from Investing Activities rose 95.11% year-over-year to -$74000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$355000.0 (up 84.03% YoY) and the FY2022 annual result came in at -$355000.0, up 84.03% from the prior year.
- Cash from Investing Activities declined to -$74000.0 in Q4 2022, from $7000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $7000.0 in Q3 2022 to a low of -$20.7 million in Q4 2019.
- A 5-year average of -$2.5 million and a median of -$418500.0 in 2020 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2018 — Cash from Investing Activities plunged 28077.04% — and 2022, when it jumped 103.85%.
- Tracing TXMD's Cash from Investing Activities over 5 years: stood at -$671171.0 in 2018, then sank by 2986.19% to -$20.7 million in 2019, then jumped by 97.62% to -$494000.0 in 2020, then slumped by 206.48% to -$1.5 million in 2021, then soared by 95.11% to -$74000.0 in 2022.
- The last three Cash from Investing Activities figures came in at -$74000.0 (Q4 2022), $7000.0 (Q3 2022), and -$76000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -74,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Mar 31, 2022 | -212,000.00 |
| Mar 31, 2022 | -212,000.00 |
| Dec 31, 2021 | -1.51 Mn |
| Dec 31, 2021 | -1.51 Mn |
| Sep 30, 2021 | -182,000.00 |
| Sep 30, 2021 | -182,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Mar 31, 2021 | -438,000.00 |
| Mar 31, 2021 | -438,000.00 |
| Dec 31, 2020 | -494,000.00 |
| Dec 31, 2020 | -494,000.00 |
| Sep 30, 2020 | -262,000.00 |
| Sep 30, 2020 | -262,000.00 |